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Article Information Abstract
Renal Disease was a chronic disease that the most attacking people in Indo-
nesia. Damage to this vital organ in the human body greatly affected a
person’s health condition, one of which was anemia. This study aimed to
determine the effectiveness of Durante hemodialysis PRC transfusions on
hemoglobin levels. The method used was Pre-experimental design, with the
One group pre-post test design approach. With a sample of 49 patients who
underwent regular hemodialysis at RSUD dr. Iskak Tulungagung. Data were
obtained by direct observation. Processed by computerized methods with a
statistical t-test, the significance level (á) was 0.05. The study results showed
that the hemoglobin levels of the pre-Durante hemodialysis PRC transfusion
patients were 4-5 mg/dl (53.06%), and the hemoglobin levels of the post-
Durante hemodialysis PRC transfusion patients were 6.1-7 mg/dl (34.69%).
The results of statistical tests showed that there was an increase in hemo-
globin levels in patients who received Durante hemodialysis PRC transfu-
sion by 1.22 mg/dl because p-value = 0.000 < 0.05 (á) means that there was an
effect.It could be concluded that the delivery of Durante hemodialysis PRC
transfusion could help increase hemoglobin levels. This finding was very
helpful for chronic Renal Disease patients undergoing hemodialysis, who
have been using erythropoietin preparations because PRC transfusions were
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INTRODUCTION
All over the world, chronic non-communicable
diseases (especially heart and blood vessel disease,
hypertension, diabetes mellitus, and chronic renal
disease) have become a major threat to public health
and health budgets. In most countries, mortality from
infectious diseases is expected to decline by 3% in
the next decade. On the other hand, chronic disease,
which currently accounts for 75% of the total burden
of disease in people over the age of 30, will increase
by 17%. The cost of treating this chronic disease
has reached 80% of the world health budget
(Yogiantoro, 2013).
Renal Disease is one of the most common
diseases affecting people in Indonesia. Renal
Disease is a condition in which the number of
nephrons in human renals is slowly damaged and
decreased. This disease can be caused by diet such
as fast food and stamina-enhancing supplements.
When the renals have decreased function, the body
tries to compensate in an adaptive and maladaptive
way, including various abnormal biochemical and
physiological complexes. The existence of Renal
Disease affects all organ systems, but the main
complications are cardiovascular, neurology,
hematology, musculoskeletal, and immunology, and
all of them get worse as renal function decreases
(Nurko, 2014).
The renal is one of the vital organs in the human
body, whose main function is to regulate fluid,
electrolytes, and body fluid composition, remove
metabolic end products from the blood, produce
hormones for the formation of red blood cells, and
regulate blood pressure. This organ comes to one
pair, and each renal weighs approximately 125
grams, which is located in the lateral position of the
lower thoracic vertebrae, 3 cm to the right and left
of the midline (Callaghan, et all, 2016).
The incidence rate of CRD is quite high. In the
United States, it is estimated that in a year, there
are 100-150 new cases of CRD for every million
population, and in Japan with a population of about
127 million people, there are approximately 20,000
people with CRD who undergo regular hemodialysis
as well as countries in Europe. In Asia, this number
is thought to be slightly lower, presumably due to
diet and lifestyle. In Indonesia, according to the
Indonesian Nephrology Association (Perhimpunan
Nefrologi Indonesia, PERNEFRI) in 2012, by
researching four major cities, namely Jakarta,
Jogjakarta, Surabaya, and Bali, there is a GGK rate
(degrees 1-5) between 2.6% and 7.5%, so that in
Indonesia, there are around 60,000 people with
CRD. This data shows a high incidence rate. The
number of new CRD patients in Indonesia is
estimated to be 5000 people each year, which of
course not all can undergo regular hemodialysis
(Suwitra, 2014).
Based on data from RSUD Dr. Iskak
Tulungagung, in June 2019, 56 Renal Disease
patients were undergoing regular hemodialysis
therapy. 31 of them needed PRC transfusion
because they had anemia, with hemoglobin levels <
7 g/dL. Of the 31 patients who received PRC
transfusions, there were 20 people whose
hemoglobin levels increased significantly, and the
others did not. This incident can be influenced by
several other factors, for example, the patient’s diet,
inadequate hemodialysis process, frequency of
reuse of the dialyzer (Re-use Dialyzer) (Suwitra,
2014).
The kidney has a very vital function, so it can
adversely affect the body’s physiological processes.
The most common kidney disorder is Chronic Renal
Disease. CRD is caused by a decrease in the
Erythropoietin hormone which plays a role in the
formation of red blood cells. As a result of the
decrease in the Erythropoietin hormone in CRD,
there is a decrease in hemoglobin levels (Brunner,
et al., 2014).
Hemoglobin is one of the blood components
contained in red blood cells (Erythrocytes). It serves
as a carrier of oxygen (O2) and carbon dioxide
(CO2) in the body. Adult’s normal Hb levels are
11.5-15.5 g/dL for women, and 13.5-17.5 g/dL for
men. If the hemoglobin level in the blood decreases,
it will affect the perfusion to the tissues and organs
throughout the body. This is commonly referred to
as anemia (Mehta, et all., 2016).
The causes of CRD are numerous and vary
from region to region. Among these causes, the most
are Diabetes Mellitus, high blood pressure
(hypertension), obesity, high cholesterol, kidney and
urinary tract infections, kidney stones, obstruction
of the urinary tract, high uric acid, congenital
disorders, and tumor (Suwitra, 2014).
The existence of this disorder causes a
decrease in kidney function to perform filtration,
reabsorption, secretion, and excretion, so that the
ability of the kidney to remove metabolic waste
substances is reduced, which in turn causes a buildup
of toxins from metabolic waste in the body of CRD
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patients. The impact of the accumulation of
metabolic waste substances is the emergence of
symptoms such as back pain, bloody or frothy urine,
urinating a lot especially at night, swelling (edema)
in the face, weakness, pale, dizziness/headache,
nausea/decreased appetite, shortness of breath,
swelling in the legs, high blood pressure, and anemia
(decreased Hemoglobin levels) due to impaired
production of the Erythropoietin hormone.
Therefore, most of the patients undergoing
hemodialysis will experience a decrease in their
hemoglobin levels and require PRC (Packed Red
Cells) transfusions. If these metabolic waste
substances are allowed to accumulate in the body,
it will be fatal to the patient’s health since they can
cause poisoning in the blood and cause death.
Treatment options to replace kidney function
include regular hemodialysis. Currently, the most
widely used is hemodialysis, but hemodialysis will
usually cause a reduction in hemoglobin levels in
patients due to a small portion of blood left on the
bloodline or dialyzer (Agustina, 2019). However, this
can be minimized by delivering PRC transfusions
during (Durante) the hemodialysis process, or by
delivering erythropoietin preparation therapy (EPO).
This EPO preparation therapy is rarely used
because of its very expensive price, so the medical
team often recommends doing PRC transfusions.
The choice of PRC transfusion therapy has several
drawbacks and potential disadvantages including
post-transfusion reactions, the risk of transmission
of infectious diseases (Hepatitis, HIV, malaria), and
can increase fluid overload which is limited to
patients with renal disease, and PRC transfusion
can only be given in certain circumstances.
Hemoglobin level for patients with chronic renal
disease is one of the factors that affect prognosis
and has a significant relationship with the patient’s
quality of life (Ardhilles, 2019). Therefore, it is
necessary to do further research on the effecti-
veness of Durante hemodialysis PRC transfusion
in increasing hemoglobin levels in patients with
chronic renal disease, considering that this PRC
transfusion is an alternative solution for patients with
chronic renal disease to maintain hemoglobin levels
within normal limits.
Materials and Methods
The design of this study is a pre-experiment
with the One Group Pre-Post Test design approach.
Respondents were patients with chronic renal
disease who underwent regular hemodialysis at
RSUD dr. Iskak Tulungagung in June 2019 totaling
49 people. The selection of respondents used the
Purposive Sampling technique, with the inclusion
criteria of patients who underwent regular
hemodialysis, patients who underwent laboratory
tests to find out their hemoglobin levels before
transfusion, patients who had anemia with Hb  7,
and Hb  8 for patients with impaired heart function,
patients who received Durante hemodialysis PRC
transfusion advice, and patients with GCS 456.
Exclusion criteria were patients with decreased
consciousness, intoxicated patients, and patients who
underwent cito hemodialysis. The independent
variable in this study was Durante hemodialysis
PRC transfusion, and the dependent variable was
the hemoglobin level. The data collection process
was carried out with a complete blood laboratory
examination of the respondent before hemodialysis
was carried out as pre-intervention hemoglobin level
data, the respondent was given PRC transfusion of
350 ml (1 single blood bag) during the hemodialysis
process. After undergoing the process of hemo-
dialysis and PRC transfusion, respondents were
given time to rest for 30 minutes then blood samples
were taken for post-intervention hemoglobin level
examination. The research data were documented
in the observation sheet.
The statistical analysis used in this research is
the Paired T-test, with the ratio data scale to




The research results are presented in the
following Table 1.
Based on the data in Table 1, it was found that
most of the respondents who were female were 31
respondents (63.2%); most of the respondents who
aged between 61-70 years were 27 respondents
(55%); most of the respondents who underwent
hemodialysis 2x/week were 37 respondents
(75.5%); most of the respondents who had
undergone hemodialysis for > 2 years were 29
respondents (59.2%), and almost all respondents
who had a non-vegetarian diet were 41 respondents
(83.7%).
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Based on the data in Table 2, it was found that
most of the respondents had Pre-PRC transfusion
Hb levels of 4-5 mg/dl (53.06%), and most of
respondents had Hb levels of 6.1-7 mg/dl (34.69%).
Based on the data in Table 3, it can be
concluded that there is a difference between the
pre-PRC transfusion Hb levels and post-PRC
transfusion Hb levels in respondents by 1.22 mg/dl.
Based on Table 4 of the statistical analysis result
above, we can get a p-value of 0.000 with a
correlation coefficient of 0.694. So we can conclude
that the p-value <  (0.000 <0.05) then H0 is
rejected, which means that there is an effect of
Durante hemodialysis PRC transfusion on the
hemoglobin levels in patients undergoing regular
hemodialysis.
DISCUSSION
From the results of the study, it is found that
most of the respondents who have not received
PRC transfusions had hemoglobin levels of 4-5 mg/
dl, as many as 26 respondents (53.06%). This
indicates that the most of patients undergoing regular
hemodialysis have low hemoglobin levels and
require transfusions. This is due to damage in the
kidney, which affects the four kidney functions,
namely filtration, reabsorption, excretion, and
secretion.
The kidneys have the function of secreting the
erythropoietin hormone, which functions to increase
the production of red blood cells in the bone marrow
(Callaghan, 2016). Therefore, if there is damage or
disturbance to the kidneys, it will also result in kidney
function, especially the function of decreasing
erythropoietin hormone secretion which results in a
decrease in hemoglobin levels in patients with
chronic renal failure, and eventually, anemia occurs.
This condition is following the statement contained
in the book by Mansjoer Arif, et al, (2013), that one
of the symptoms of chronic renal disease in the
hematological system is anemia, immune deficiency,
and easy bleeding. The presence of bleeding causes
anemia in patients with renal failure caused by the
deficiency of the erythropoietin hormone (Mansjoer,
et al, 2013).
This anemia condition is also exacerbated by
other symptoms of renal disease such as bleeding
too easily in renal disease patients, so the risk of
anemia in renal disease patients is also getting bigger.
Therefore, in patients with renal disease, there is a
decrease in hemoglobin levels (Suwitra, 2014).
Variable N %
Gender Male 18 36.7
Female 31 63.2
Age 40-50 years old 8 16.2
51-60 years old 13 26.4
61-70 years old 27 55
71-80 years old 1 2.4
HD Interval 1x/week 5 10.2
2x/week 37 75.5
5 days once 7 14.3
HD Duration < 6 months 5 10.2
6-12 months 15 30.6
> 2 years 29 59.2
Diet Vegetarian 8 16.3
Non Vegetarian 41 83.7
Table 1 Frequency Distribution of Respondents based
on General Data
Variable N %










Table 2 Frequency Distribution of respondents’ hemo-
globin levels before and after receiving Durante
hemodialysis PRC transfusions
Hb Level Frequency Mean SD
Pre-transfusion 49 5.18 0.70066
Post-transfusion 49 6.4 1.05308




Post-transfusion 49 0.694 0.000
Hb Level
Table 4 Statistical analysis result
    17Girianto, Mulyasari, The Effectiveness of Durante Hemodialysis Packed Red Cells  ...
Based on the results of the study, most of the
respondents who had received Packed Red Cells
(PRC) transfusions experienced an increase in
hemoglobin levels to 6.1-7 mg/dl by 17 respondents
(34.69%), and a small proportion of their hemoglobin
levels were still low, ranging from 4-5 mg/dl by 6
respondents (12.25%). This situation indicates that
most of the regular hemodialysis patients who had
received Packed Red Cells (PRC) transfusions
experienced a significant increase in hemoglobin
levels. The increase in hemoglobin levels is due to
the transfusion given is a concentrated red blood
cell concentrate. So that it is expected to increase
hemoglobin levels in renal disease patients who have
anemia.
These concentrated red blood cells are used to
increase the number of red blood cells showing
symptoms of anemia, and only require additional
red blood cell mass, such as in patients with renal
disease or malignancy (cancer). The advantage is
improved oxygenation and increased levels of
erythrocytes (red blood cells) without an increase
in volume load, so it is safe if given to renal disease
patients who have complications of heart failure.
However, deficiency can cause hypervolemia if
given in large quantities and for a short time. Every
1 unit of concentrated red blood cells (PRC) can
increase hemoglobin levels by around 1 mg/dl or
hematocrit by 3-4% (Haroen, 2012).
According to Haroen (2012), PRC transfusion
is more widely used to increase hemoglobin levels
in renal disease patients who have anemia, due to
its minimal side effects, and an affordable price
compared to the use of erythropoietin (EPO)
preparations which are quite expensive and side
effects that can aggravate the work of the heart. It
is expected that by delivering Durante hemodialysis
PRC transfusions, the hemoglobin levels of patients
with renal disease who have anemia can increase,
with side effects that can be minimized. So that it
will be more effective and efficient, as well as great
benefits for the development of patients’ health with
renal disease.
From the results of data analysis using the T
paired t-test statistical test, the value of P value =
0.000 is obtained. This shows that the P value =
0.000 <  = 0.05 which indicates that H0 is failed to
be rejected. And the coefficient is positive, this
shows that the independent variable and the
dependent variable are directly proportional. Patients
who receive Packed Red Cells (PRC) transfusions
during the hemodialysis process will experience an
increase in hemoglobin levels. So it can be
concluded that there is an effect of PRC transfusion
on hemoglobin levels in patients undergoing regular
hemodialysis. This proves that the delivery of
Durante hemodialysis PRC transfusions can help
increase hemoglobin levels in hemodialysis patients
who are in anemia. Because PRC contains
concentrated red blood cells with a high enough
concentration.
Pre-PRC transfusion hemoglobin levels in most
renal disease patients undergoing regular hemo-
dialysis have decreased. This is due to decreased
function of the erythropoietin hormone secretion by
the kidneys, as a result of impaired kidney function.
This function cannot be replaced by the hemodialysis
process, since the dialyzer function is only limited
to filtration (Price, 2016).
PRC transfusion is an appropriate therapy given
to patients with renal disease due to its effecti-
veness, and there are no side effects that can
aggravate the works of the heart and kidney so it is
safe to use. Besides, the cost is also affordable,
when compared to the erythropoietin (EPO)
preparation which is quite expensive (Supandiman,
2016).
The hemoglobin level of patients with renal
disease is also influenced by many factors, including
age, the interval of hemodialysis therapy, length of
time undergoing hemodialysis therapy, and patient’s
diet. Age is a factor that can affect hemoglobin level
in patients with renal disease, due to degenerative
processes that can result in the decreased systemic
function of the body, coupled with interference with
kidney function, so that it can exacerbate anemia
symptoms that occur in patients with renal disease.
The next factor is the interval of the hemodialysis
therapy, the determination of this interval depends
on the general condition of the patient with renal
disease. If the general condition is good, then the
patient will be advised to undergo hemodialysis once
a week, and if the general condition is weak, the
patient will undergo hemodialysis twice a week.
This can affect the patients’ hemoglobin levels,
because the more often the patients undergo
hemodialysis, the more risk of anemia will be if it is
not balanced with the things recommended by the
medical team. This situation is caused by the
hemodialysis process which uses acid and
bicarbonate as the dialysate. This fluid has an effect
that can damage red blood cells so that it will affect
the hemoglobin levels of patients undergoing
hemodialysis in the long term. Therefore, the length
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of time undergoing hemodialysis therapy also
becomes the factor that affects the hemoglobin
levels in renal disease patients (PPGII Jatim, 2011).
The last factor is the patient’s diet. A small
percentage of hemodialysis patients have a
vegetarian diet because on average, they also have
hypertension and heart disease. Lack of
consumption of meat and iron is what ultimately
triggers anemia in kidney disease patients. However,
it is not absolute that diet affects hemoglobin levels
in patients undergoing regular hemodialysis.
Therefore, regular hemodialysis patients who
experience complications in the form of
hypertension or heart disease are recommended not
to adopt an absolute vegetarian diet, so that the
patients’ hemoglobin levels do not tend to fall
(PERNEFRI, 2012).
From the discussion above, it can be concluded
that the PRC transfusion is better, more effective,
and more efficient to increase hemoglobin levels in
patients with renal disease who have anemia. With
various advantages, such as hemoglobin levels can
increase significantly, prices are likely to be
affordable if compared with other therapies for
anemia, side effects that are not harmful to the heart,
and there is no risk of hypervolemia if delivered in
the correct dosage and manner (Pinheiro, 2018).
CONCLUSION
Based on the results of the study and discussion,
we can conclude that most renal disease patients
who underwent regular hemodialysis (53.06%), had
low hemoglobin levels (4-5 mg/dl) before being given
Packed Red Cells (PRC) transfusions. Most of the
renal disease patients who underwent regular
hemodialysis (34.69%), had hemoglobin levels of
6.1-7 mg/dl after receiving Durante hemodialysis
Packed Red Cell (PRC) transfusions. There is an
effect of giving Durante hemodialysis Packed Red
Cells (PRC) transfusions on hemoglobin levels in
renal disease patients undergoing regular
hemodialysis.
SUGGESTION
For renal disease patients undergoing regular
hemodialysis with symptoms of anemia, it is
necessary to consider getting transfusions according
to the doctor’s advice so as not to worsen the
anemia experienced by the patients. Besides,
maintaining a diet so that it can help the formation
of new red blood cells, so it is expected that anemia
does not occur. The medical team should
recommend giving Packed Red Cells (PRC)
transfusions to patients with renal disease who have
anemia because of its proven effectiveness to
increase hemoglobin levels, and there are no side
effects that can aggravate the kidney and heart.
Also, the cost is relatively cheap when compared
with the delivery of erythropoietin preparations. For
other researchers who want to continue this
research, confounding variables in this study should
be removed, and respondents can be made more
homogeneous by adding inclusion criteria so that
the research results become more valid.
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